CWM
PTCT icon

CIBC World Markets’s PTC Therapeutics PTCT Stock Holding History

CIBC World Markets’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$391K Buy
+5,142
New +$374K ﹤0.01% 882
2025
Q2 		$468K Sell
9,577
-7,323
-43% -$348K ﹤0.01% 902
2025
Q1 		$861K Buy
16,900
+9,773
+137% +$488K 0.01% 746
2024
Q4 		$322K Buy
+7,127
New +$305K ﹤0.01% 899
2024
Q2 		– Sell
-150,000
Closed -$4.36M – 780
2024
Q1 		$4.36M Buy
+150,000
New +$4.2M 0.03% 348

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CIBC World Markets's PTCT Position: Q4 2025 in Review

CIBC World Markets opened a new position in PTC Therapeutics (PTCT) in Q4 2025: 5,142 shares worth $391K. The stake represents ﹤0.01% of the portfolio and ranks #882 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in PTCT as recently as Q2 2025.

CIBC World Markets first reported a position in PTCT in Q1 2024 and has held it in 5 quarters since. The position peaked at $4.36M in Q1 2024. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • CIBC World Markets held 5,142 shares of PTC Therapeutics worth $391K as of Q4 2025.
  • PTC Therapeutics was a new CIBC World Markets position in Q4 2025.
  • PTC Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #882 holding.
  • CIBC World Markets first reported a position in PTC Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • CIBC World Markets's PTC Therapeutics position peaked at $4.36M in Q1 2024.
  • 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.